First-trimester uterine artery Doppler analysis in the prediction of later pregnancy complications

Su Lynn Khong, Stefan C Kane, Shaun P Brennecke, Fabrício da Silva Costa, Su Lynn Khong, Stefan C Kane, Shaun P Brennecke, Fabrício da Silva Costa

Abstract

Uterine artery Doppler waveform analysis has been extensively studied in the second trimester of pregnancy as a predictive marker for the later development of preeclampsia and fetal growth restriction. The use of Doppler interrogation of this vessel in the first trimester has gained momentum in recent years. Various measurement techniques and impedance indices have been used to evaluate the relationship between uterine artery Doppler velocimetry and adverse pregnancy outcomes. Overall, first-trimester Doppler interrogation of the uterine artery performs better in the prediction of early-onset than late-onset preeclampsia. As an isolated marker of future disease, its sensitivity in predicting preeclampsia and fetal growth restriction in low risk pregnant women is moderate, at 40-70%. Multiparametric predictive models, combining first-trimester uterine artery pulsatility index with maternal characteristics and biochemical markers, can achieve a detection rate for early-onset preeclampsia of over 90%. The ideal combination of these tests and validation of them in various patient populations will be the focus of future research.

Figures

Figure 1
Figure 1
Transabdominal Doppler interrogation of the uterine artery at the level of the internal cervical os. Uterine artery waveform demonstrating raised PI with an early diastolic notch (arrow). Reproduced with permission from Associate Professor F. da Silva Costa.
Figure 2
Figure 2
Transvaginal Doppler interrogation of the uterine artery at the cervicocorporeal junction. Normal uterine artery waveforms. Reproduced with permission from Associate Professor F. da Silva Costa.

References

    1. Cantwell R., Clutton-Brock T., Cooper G., et al. Saving Mothers' Lives: reviewing maternal deaths to make motherhood safer: 2006–2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in theThe eighth report of the confidential enquiries into maternal deaths in the United Kingdom. BJOG. 2011;118(supplement 1):1–203.
    1. Kane S. C., Da Silva Costa F., Brennecke S. First trimester biomarkers in the prediction of later pregnancy complications. BioMed Research International. 2014;2014:6. doi: 10.1155/2014/807196.807196
    1. Wallace A. E., Host A. J., Whitley G. S., Cartwright J. E. Decidual natural killer cell interactions with trophoblasts are impaired in pregnancies at increased risk of preeclampsia. The American Journal of Pathology. 2013;183(6):1853–1861. doi: 10.1016/j.ajpath.2013.08.023.
    1. Wallace A. E., Whitley G. S., Thilaganathan B., Cartwright J. E. Decidual natural killer cell receptor expression is altered in pregnancies with impaired vascular remodeling and a higher risk of pre-eclampsia. Journal of Leukocyte Biology. 2015;97(1):79–86. doi: 10.1189/jlb.2a0614-282r.
    1. Brosens I., Pijnenborg R., Vercruysse L., Romero R. The ‘great Obstetrical Syndromes’ are associated with disorders of deep placentation. American Journal of Obstetrics and Gynecology. 2011;204(3):193–201. doi: 10.1016/j.ajog.2010.08.009.
    1. Carbillon L., Challier J. C., Alouini S., Uzan M., Uzan S. Uteroplacental circulation development: doppler assessment and clinical importance. Placenta. 2001;22(10):795–799. doi: 10.1053/plac.2001.0732.
    1. Everett T. R., Lees C. C. Beyond the placental bed: placental and systemic determinants of the uterine artery Doppler waveform. Placenta. 2012;33(11):893–901. doi: 10.1016/j.placenta.2012.07.011.
    1. Tuuli M. G., Odibo A. O. First- and second-trimester screening for preeclampsia and intrauterine growth restriction. Clinics in Laboratory Medicine. 2010;30(3):727–746. doi: 10.1016/j.cll.2010.05.002.
    1. Zhong Y., Tuuli M., Odibo A. O. First-trimester assessment of placenta function and the prediction of preeclampsia and intrauterine growth restriction. Prenatal Diagnosis. 2010;30(4):293–308. doi: 10.1002/pd.2475.
    1. Alves J. A. G., Silva B. Y. D. C., Sousa P. C. P. D., Maia S. B., Costa F. D. S. Reference range of uterine artery Doppler parameters between the 11th and 14th pregnancy weeks in a population sample from Northeast Brazil. Revista Brasileira de Ginecologia e Obstetrícia. 2013;35(8) doi: 10.1590/s0100-72032013000800004.
    1. Gómez O., Figueras F., Fernández S., et al. Reference ranges for uterine artery mean pulsatility index at 11–41 weeks of gestation. Ultrasound in Obstetrics & Gynecology. 2008;32(2):128–132. doi: 10.1002/uog.5315.
    1. Lefebvre J., Demers S., Bujold E., et al. Comparison of two different sites of measurement for transabdominal uterine artery Doppler velocimetry at 11–13 weeks. Ultrasound in Obstetrics and Gynecology. 2012;40(3):288–292. doi: 10.1002/uog.11137.
    1. Plasencia W., Barber M. A., Alvarez E. E., Segura J., Valle L., Garcia-Hernandez J. A. Comparative study of transabdominal and transvaginal uterine artery doppler pulsatility indices at 11–13 + 6 weeks. Hypertension in Pregnancy. 2011;30(4):414–420. doi: 10.3109/10641955.2010.506232.
    1. Ridding G., Schluter P. J., Hyett J. A., McLennan A. C. Uterine artery pulsatility index assessment at 11–13 weeks' gestation. Fetal Diagnosis & Therapy. 2014;36:299–304.
    1. Sciscione A. C., Hayes E. J. Uterine artery doppler flow studies in obstetric practice. American Journal of Obstetrics & Gynecology. 2009;201(2):121–126. doi: 10.1016/j.ajog.2009.03.027.
    1. Mo L. Y. L., Bascom P. A. J., Ritchie K., McCowan L. M. E. A transmission line modelling approach to the interpretation of uterine Doppler waveforms. Ultrasound in Medicine & Biology. 1988;14(5):365–376. doi: 10.1016/0301-5629(88)90072-5.
    1. Cnossen J. S., Morris R. K., Ter Riet G., et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. Canadian Medical Association Journal. 2008;178(6):701–711. doi: 10.1503/cmaj.070430.
    1. National Institute for Health and Clinical Excellence. Guidance: Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. National Institute for Health and Clinical Excellence; 2010.
    1. Khalil A., Nicolaides K. H. How to record uterine artery Doppler in the first trimester. Ultrasound in Obstetrics & Gynecology. 2013;42(4):478–479. doi: 10.1002/uog.12366.
    1. Steegers E. A. P., von Dadelszen P., Duvekot J. J., Pijnenborg R. Pre-eclampsia. The Lancet. 2010;376(9741):631–644. doi: 10.1016/s0140-6736(10)60279-6.
    1. Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension. 2008;51(4):970–975. doi: 10.1161/hypertensionaha.107.107607.
    1. Visser G. H. A., Bilardo C. M., Lees C. Fetal growth restriction at the limits of viability. Fetal Diagnosis & Therapy. 2014;36:162–165. doi: 10.1159/000358058.
    1. de Boo H. A., Harding J. E. The developmental origins of adult disease (Barker) hypothesis. Australian & New Zealand Journal of Obstetrics and Gynaecology. 2006;46(1):4–14. doi: 10.1111/j.1479-828x.2006.00506.x.
    1. Gómez O., Martínez J. M., Figueras F., et al. Uterine artery Doppler at 11-14 weeks of gestation to screen for hypertensive disorders and associated complications in an unselected population. Ultrasound in Obstetrics & Gynecology. 2005;26(5):490–494. doi: 10.1002/uog.1976.
    1. Melchiorre K., Sharma R., Thilaganathan B. Cardiovascular implications in preeclampsia: an overview. Circulation. 2014;130(8):703–714. doi: 10.1161/circulationaha.113.003664.
    1. Verlohren S., Melchiorre K., Khalil A., Thilaganathan B. Uterine artery Doppler, birth weight and timing of onset of pre-eclampsia: providing insights into the dual etiology of late-onset pre-eclampsia. Ultrasound in Obstetrics & Gynecology. 2014;44(3):293–298. doi: 10.1002/uog.13310.
    1. Figueras F., Gratacós E. Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagnosis & Therapy. 2014;36:86–98. doi: 10.1159/000357592.
    1. Velauthar L., Plana M. N., Kalidindi M., et al. First-trimester uterine artery Doppler and adverse pregnancy outcome: a meta-analysis involving 55 974 women. Ultrasound in Obstetrics & Gynecology. 2014;43(5):500–507. doi: 10.1002/uog.13275.
    1. Plasencia W., Maiz N., Poon L., Yu C., Nicolaides K. H. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia. Ultrasound in Obstetrics & Gynecology. 2008;32(2):138–146. doi: 10.1002/uog.5402.
    1. Gómez O., Figueras F., Martínez J. M., et al. Sequential changes in uterine artery blood flow pattern between the first and second trimesters of gestation in relation to pregnancy outcome. Ultrasound in Obstetrics and Gynecology. 2006;28(6):802–808. doi: 10.1002/uog.2814.
    1. Svirsky R., Yagel S., Ben-Ami I., Cuckle H., Klug E., Maymon R. First trimester markers of preeclampsia in twins: maternal mean arterial pressure and uterine artery Doppler pulsatility index. Prenatal Diagnosis. 2014;349(10):956–960. doi: 10.1002/pd.4402.
    1. Geipel A., Hennemann F., Fimmers R., et al. Reference ranges for Doppler assessment of uterine artery resistance and pulsatility indices in dichorionic twin pregnancies. Ultrasound in Obstetrics and Gynecology. 2011;37(6):663–667. doi: 10.1002/uog.8859.
    1. Duckitt K., Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. British Medical Journal. 2005;330(7491):p. 565. doi: 10.1136/bmj.38380.674340.e0.
    1. Poon L. C. Y., Staboulidou I., Maiz N., Plasencia W., Nicolaides K. H. Hypertensive disorders in pregnancy: screening by uterine artery Doppler at 11–13 weeks. Ultrasound in Obstetrics & Gynecology. 2009;34(2):142–148. doi: 10.1002/uog.6452.
    1. Napolitano R., Rajakulasingam R., Memmo A., Bhide A., Thilaganathan B. Uterine artery Doppler screening for pre-eclampsia: comparison of the lower, mean and higher first-trimester pulsatility indices. Ultrasound in Obstetrics & Gynecology. 2011;37(5):534–537. doi: 10.1002/uog.8848.
    1. Poon L. C. Y., Karagiannis G., Leal A., Romero X. C., Nicolaides K. H. Hypertensive disorders in pregnancy: screening by uterine artery Doppler imaging and blood pressure at 11–13 weeks. Ultrasound in Obstetrics & Gynecology. 2009;34(5):497–502. doi: 10.1002/uog.7439.
    1. Allen R. E., Rogozinska E., Cleverly K., Aquilina J., Thangaratinam S. Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2014;182:194–201. doi: 10.1016/j.ejogrb.2014.09.027.
    1. Poon L. C. Y., Kametas N. A., Maiz N., Akolekar R., Nicolaides K. H. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension. 2009;53(5):812–818. doi: 10.1161/hypertensionaha.108.127977.
    1. Farina A., Rapacchia G., Freni Sterrantino A., Pula G., Morano D., Rizzo N. Prospective evaluation of ultrasound and biochemical-based multivariable models for the prediction of late pre-eclampsia. Prenatal Diagnosis. 2011;31(12):1147–1152. doi: 10.1002/pd.2849.
    1. Thornton C., Dahlen H., Korda A., Hennessy A. The incidence of preeclampsia and eclampsia and associated maternal mortality in Australia from population-linked datasets: 2000–2008. American Journal of Obstetrics & Gynecology. 2013;208(6):476.e1–476.e5. doi: 10.1016/j.ajog.2013.02.042.
    1. Martin A., Krishna I., Martina B., Samuel A. Can the quantity of cell-free fetal DNA predict preeclampsia: a systematic review. Prenatal Diagnosis. 2014;34:685–691. doi: 10.1002/pd.4416.
    1. Rolnik D. L., O'Gorman N., Fiolna M., van den Boom D., Nicolaides K. H., Poon L. C. Maternal plasma cell-free DNA in the prediction of pre-eclampsia. Ultrasound in Obstetrics & Gynecology. 2015;45(1):106–111. doi: 10.1002/uog.14671.
    1. Karagiannis G., Akolekar R., Sarquis R., Wright D., Nicolaides K. H. Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11–13 weeks. Fetal Diagnosis and Therapy. 2011;29(2):148–154. doi: 10.1159/000321694.
    1. Poon L. C. Y., Syngelaki A., Akolekar R., Lai J., Nicolaides K. H. Combined screening for preeclampsia and small for gestational age at 11–13 weeks. Fetal Diagnosis and Therapy. 2013;33(1):16–27. doi: 10.1159/000341712.
    1. Crovetto F., Crispi F., Scazzocchio E., et al. First-trimester screening for early and late small-for-gestational-age neonates using maternal serum biochemistry, blood pressure and uterine artery Doppler. Ultrasound in Obstetrics and Gynecology. 2014;43(1):34–40. doi: 10.1002/uog.12537.
    1. Duley L., Henderson-Smart D. J., Meher S., King J. F. Antiplatelet agents for preventing pre-eclampsia and its complications (review) The Cochrane Database of Systematic Reviews. 2007;(2):p. 121. doi: 10.1002/14651858.CD004659.pub2.CD004659
    1. Bujold E., Roberge S., Lacasse Y., et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy a meta-analysis. Obstetrics & Gynecology. 2010;116:402–414.
    1. Cnossen J. S., Riet G. T., Mol B. W., et al. Are tests for predicting pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal. Acta Obstetricia et Gynecologica Scandinavica. 2009;88(7):758–765. doi: 10.1080/00016340903008953.
    1. Costa S. L., Proctor L., Dodd J. M., et al. Screening for placental insufficiency in high-risk pregnancies: is earlier better? Placenta. 2008;29(12):1034–1040. doi: 10.1016/j.placenta.2008.09.004.
    1. Nicolaides K. H. Turning the pyramid of prenatal care. Fetal Diagnosis and Therapy. 2011;29(3):183–196. doi: 10.1159/000324320.
    1. Poon L. C., Nicolaides K. H. Early prediction of preeclampsia. Obstetrics and Gynecology International. 2014;2014:11. doi: 10.1155/2014/297397.297397
    1. Parra-Cordero M., Rodrigo R., Barja P., et al. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy. Ultrasound in Obstetrics & Gynecology. 2013;41(5):538–544. doi: 10.1002/uog.12264.
    1. Odibo A. O., Zhong Y., Goetzinger K. R., et al. First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia. Placenta. 2011;32(8):598–602. doi: 10.1016/j.placenta.2011.05.006.
    1. Poon L. C. Y., Maiz N., Valencia C., Plasencia W., Nicolaides K. H. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound in Obstetrics & Gynecology. 2009;33(1):23–33. doi: 10.1002/uog.6280.
    1. Scazzocchio E., Figueras F., Crispi F., et al. Performance of a first-trimester screening of preeclampsia in a routine care low-risk setting. American Journal of Obstetrics and Gynecology. 2013;208(3):203.e1–203.e10. doi: 10.1016/j.ajog.2012.12.016.
    1. Crovetto F., Figueras F., Triunfo S., et al. First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters and angiogenic factors. Prenatal Diagnosis. 2015;35(2):183–191. doi: 10.1002/pd.4519.
    1. Poon L. C. Y., Akolekar R., Lachmann R., Beta J., Nicolaides K. H. Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11–13 weeks. Ultrasound in Obstetrics and Gynecology. 2010;35(6):662–670. doi: 10.1002/uog.7628.
    1. Poon L. C. Y., Stratieva V., Piras S., Piri S., Nicolaides K. H. Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11–13 weeks. Prenatal Diagnosis. 2010;30(3):216–223. doi: 10.1002/pd.2440.
    1. Akolekar R., Syngelaki A., Sarquis R., Zvanca M., Nicolaides K. H. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks. Prenatal Diagnosis. 2011;31(1):66–74. doi: 10.1002/pd.2660.
    1. Akolekar R., Syngelaki A., Poon L., Wright D., Nicolaides K. H. Competing risks model in early screening for preeclampsia by biophysical and biochemical markers. Fetal Diagnosis and Therapy. 2013;33(1):8–15. doi: 10.1159/000341264.
    1. Oliveira N., Magder L. S., Blitzer M. G., Baschat A. A. First-trimester prediction of pre-eclampsia: external validity of algorithms in a prospectively enrolled cohort. Ultrasound in Obstetrics & Gynecology. 2014;44(3):279–285. doi: 10.1002/uog.13435.
    1. Park F. J., Leung C. H. Y., Poon L. C. Y., Williams P. F., Rothwell S. J., Hyett J. A. Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2013;53(6):532–539. doi: 10.1111/ajo.12126.
    1. Skråstad R., Hov G., Blaas H., Romundstad P., Salvesen K. Risk assessment for preeclampsia in nulliparous women at 11–13 weeks gestational age: prospective evaluation of two algorithms. British Journal of Obstetrics and Gynaecology. 2014 doi: 10.1111/1471-0528.13194.

Source: PubMed

Szponzorok és közreműködők

Egészségi állapot

Kábítószer-beavatkozások

3
Iratkozz fel